Key Takeaways
- Volume recovery underway, pricing still under siege: Q4 volumes grew 12% QoQ with double-digit growth in both domestic and export markets, but realizations dropped 6.5% sequentially as Chinese dumping continued to pressure selling prices.
- Margins have likely troughed: EBITDA margin fell 220 bps YoY to 13.5% in FY24, but management believes the bottom is in and stabilization should follow, supported by new customer additions and operating leverage.
- Specialty weakness persists but is stabilizing: Latex specialty volumes remain ~40% below FY22 peaks, though management sees the worst as over and expects gradual improvement from here.
- Capacity expansion signals confidence: A ₹250 crore investment at Dahej was approved to debottleneck products already running at 95–100% utilization, with commercial activity expected in H2 FY27.
- What to watch next quarter: Whether the Q4 volume base holds as a floor for FY25, the trajectory of Chinese dumping as domestic demand there evolves, and any margin recovery as raw material and realization spreads stabilize.
Volume & Demand Recovery
- Broad-based sequential rebound: Q4 volume growth of 12% QoQ was driven by both domestic and export markets, with growth distributed roughly uniformly across new and existing customers. Domestic volumes were higher single digits, exports a little higher.
- Export resilience: FY24 export volume grew 9% YoY despite geopolitical headwinds and fluctuating raw material prices, driven by non-Latex rubber chemicals. Strategic engagement with global customers is gaining traction.
- Domestic tyre demand supportive: The Indian tyre industry is expected to grow mid-single digits in FY25, supported by a stable replacement segment and growing OEM segments in passenger vehicles and two-wheelers. The CV replacement market is expected to turn positive post-elections as infrastructure initiatives ramp up.
- Non-tyre growth tailwind: Robust growth is expected in non-tyre sectors, with penetrated market presence in tyre retreading and auto components. CV radialization and the focus on sustainable tyres augur well for retreading demand.
- Tyre exports remain a drag: Tyre exports have been subdued since June 2022 and are expected to see only modest growth in the near term due to muted demand in the US and Europe.
- Confidence building: Management's confidence level is higher than 12 months ago, with new customers added in recent months expected to contribute alongside further additions over the next 9–12 months. Q4 FY24 volumes are considered a base for FY25, with quarter-on-quarter buildup expected.
P. Srinivasan: "Definitely. We are already seeing some tractions emerging that the bottom most period is over. We have actually started consolidating something and as time goes along, we expect to show some improvements. We cannot expect to recover back to 100. The 60 will go gradually to 65, thereabout something like that."
Pricing & Chinese Dumping
- Realization hit from dumping: Selling price dropped 6.5% QoQ due to aggressive dumping from China and other markets, which also muted domestic volume growth. The company is managing a balanced approach between price and volume.
- Raw material pass-through: The ~10% drop in Q4 realizations was accompanied by a corresponding drop in raw material prices. The value-addition component is where profitability parameters may be impacted, not the raw material pass-through itself.
- No timeline for relief: Chinese dumping is expected to continue unless domestic consumption in China picks up. Management offered no timeline for subsidence, tying it entirely to Chinese domestic demand recovery.
- China-plus-one as structural defense: NOCIL's value proposition to global customers centers on a China de-risking strategy, with customers seeking long-term supply reliability outside China. This structural shift provides a demand floor even as pricing remains under pressure.
V. S. Anand: "I think it's also a factor of how much the domestic consumption in China picks up and I think until then they're going to be looking at markets to push their products or dump their products and I think it will stay on unless domestic volumes pick up."
Margins & Cost Structure
- FY24 margin compression: EBITDA margin declined to 13.5% in FY24 from 15.7% in FY23, a drop of 220 bps, driven by pricing pressure and the operating leverage impact of lower volumes earlier in the year.
- Bottoming signal: Management's sense is that margins have bottomed out and should not go further below current levels. With new businesses coming in, margins should hold up in good stead. The possibility exists to return to normal spreads historically seen.
- Other expenses optically higher, actually lower: Other expenses as a percentage of revenue rose 140 bps YoY, but this is purely arithmetic from a lower revenue denominator. On a per-metric-ton basis, other expenses have actually come down.
- Operating leverage from utilities: Q4 benefited from operational excellence initiatives in manufacturing, particularly utilities efficiencies. Utility costs are down 15–20%, a combination of per-unit price benefits and efficiency measures.
- Power cost structure offers further leverage: A fixed component in power cost means that as volumes ramp up, operating leverage benefits will accrue from that fixed portion. The company is also working on power co-generation, which will add to benefits as volumes increase.
- Freight impact manageable: Recent freight cost increases and container shortages are not very significant for NOCIL. The company has been able to discuss mitigation with customers and does not see any significant impact on contribution margins.
V. S. Anand: "I wouldn't put my finger and say that there will only be marginal impact from here on because we continue to keep working on it. And I'm always positive that we will find more and more areas in that space. So, I'd never say that we have reached a certain plateau."
Capacity Expansion & Capex
- ₹250 crore Dahej expansion approved: The board has approved a ₹250 crore investment at the Dahej site for further expansion of rubber chemical capacities. Work has already begun.
- Debottlenecking peak-utilization products: While overall capacity utilization is 65%, this masks individual product-level realities. Some products are already at 95–100% capacity, and the new investment is targeted at these constrained products to capture further growth opportunities.
- Timeline: The expansion will be commissioned in 2.5 years, with an endeavor to complete faster. Commercial activity may start in the second half or later half of FY27.
- Product details withheld: Management declined to disclose which specific product categories (accelerators, antioxidants, or specialties) the new capacity targets, citing business confidentiality. Disclosure will come at an appropriate future time.
- Green investments: Solar panels are being installed at both plants, and green energy sourcing and cogeneration have been implemented, expected to reduce the carbon footprint.
Specialty Chemicals & Diversification
- Latex specialty still deeply depressed: Latex specialty volumes have degrown ~40% from FY22 levels, with the index falling from 100 to approximately 50–60. Some sequential improvement was seen in certain specialty products but not at a significant level.
- Gradual recovery, not a snapback: Management sees the bottom-most period as over and expects gradual improvement from ~60 to ~65 on the index, not a return to 100. Traction is emerging, and consolidation has begun.
- New chemistry diversification in progress: Work on diversification into new chemistries is underway and continuing, but management finds it very difficult to put a timeline on announcements, as discussions are at different stages and they cannot share until they get real conformity.
- Molecule longevity as a moat: Some of NOCIL's molecules have been in use for 50–60 years, with performance characteristics that have proven very challenging to improve upon. This creates a durable demand profile even as the company explores new chemistries.
V. S. Anand: "I think some of these molecules are there for the last 50 to 60 years. I think partially we can also say that these have been real strong work offers that it's also been very challenging to get better ones than this from a performance point of view."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth | Q4 FY24 volumes as base, with quarter-on-quarter buildup expected | FY25 |
| Latex specialty recovery | Gradual improvement from index ~60 to ~65, not back to 100 | Gradual, no fixed timeline |
| Margin stabilization | Margins have bottomed out, should not go further below current levels; possibility to return to normal historical spreads | Conditional on Chinese domestic demand recovery |
| Capacity expansion commissioning | ₹250 crore Dahej expansion, commercial activity start | H2 FY27 or later half |
| Chinese dumping relief | Subsidence contingent on Chinese domestic consumption picking up | No timeline |
V. S. Anand: "Our clear value proposition, which our customers see from somebody like a supplier of NOCIL is one is the China de-risking strategy which is China plus one and they're looking at long-term supply reliability."
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Revenue from operations | ₹356 cr, +5% QoQ |
| Net revenue from operations | ₹357 cr, vs ₹341 cr in Q3 FY24, +5% QoQ |
| Net revenue from operations (full year) | ₹1,445 cr, vs ₹1,617 cr in FY23 |
| Operating EBITDA | ₹45 cr, vs ₹49 cr in Q3 FY24 |
| EBITDA margin | 12.5%–13.5%, vs 14.3% in Q3 FY24 |
| EBITDA margin (full year) | 13.5%, vs 15.7% in FY23, a drop of 220 bps |
| Profit before tax | ₹56 cr, vs ₹41 cr in Q3 FY24 |
| Profit after tax | ₹42 cr, vs ₹30 cr in Q3 FY24 |
| PAT (full year) | ₹133 cr, vs ₹149 cr in FY23 |
| Volume index (base Q1 FY20=100) | 138, +12% QoQ |
| Selling price change | -6.5% QoQ |
| Export volume growth (full year) | 9% YoY |
| Overall volume growth (full year) | ~2% YoY, domestic flattish |
| Export share of revenue | ~33%–34% |
| Latex specialty volume index (FY22=100) | ~50–60, ~40% degrowth from FY22 |
| Overall capacity utilization (full year) | ~65% |
| Other income | ₹25 cr, includes ₹18 cr profit on sale of fixed assets |
| Board-approved capacity expansion | ₹250 cr at Dahej site, commissioning expected in 2.5 years |